載入...
Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
Na minha lista:
| 發表在: | EClinicalMedicine |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6933181/ https://ncbi.nlm.nih.gov/pubmed/31891147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.11.009 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|